Ajaykumar Umakant Mahajan

Evaluation of Balloon Expandable Transcatheter Heart Valve in the Treatment of Severe Symptomatic Native Aortic Stenosis: The First-in-human MyVal-1 Study Open

Ravinder Singh Rao, Samin K. Sharma, Praveen Chandra, Gunasekaran Sengottovelu, Prashant Bharadwaj , et al. · 2020

Objective: To demonstrate safety and efficacy of the next-generation balloon-expandable CE-approved Myval™ THV in intermediate or high-risk patient population with severe symptomatic native aortic stenosis. Methods: We enrolled 100 patient…

Corrigendum to “Cardiological Society of India position statement on management of heart failure in India” [Indian Heart J 70 (S1) (2018) S1–S72] Open

Santanu Guha, S Harikrishnan, Saumitra Ray, Rishi Sethi, S Ramakrishnan , et al. · 2018

CSI position statement on management of heart failure in India Open

Santanu Guha, S Harikrishnan, Saumitra Ray, Rishi Sethi, S Ramakrishnan , et al. · 2018

Pharmacokinetic Study of Sirolimus-Eluting BioResorbable Vascular Scaffold System for Treatment of <i>De Novo</i> Native Coronary Lesions: A Sub-Study of MeRes-1 Trial Open

Praveen Chandra, Ajaykumar Umakant Mahajan, Vipin D. Bulani, Ashok Thakkar · 2018

The MeRes-1 pharmacokinetic sub-study confirmed that MeRes100 BRS is safe and tolerable at limited systemic exposure of sirolimus.

Prevalence and predictors of ventriculoatrial conduction in structurally normal hearts Open

Ganesh C. Patil, Sachin Gavade, Umesh Khedkar, Ajaykumar Umakant Mahajan, Pratap Nathani · 2015

Study of left ventricular diastolic function following percutaneous coronary intervention for left anterior descending coronary artery disease in patients with normal left ventricular systolic function Open

Shaikh Zohaib Farooque, Khedkar Umesh, Gavade Sachin, Ganesh Patil, Ajaykumar Umakant Mahajan , et al. · 2015

Ajaykumar Umakant Mahajan YOU? Author Swipe